NHS and Sobi UK have come to an agreement that will give people living with haemophilia A in the UK increased access to Elocta, by lifting prior volume restrictions for the drug. Elocta is licensed by the European Commission in all age groups for treatment and prevention of bleeding in patients with haemophilia A. It
Date: Thursday, July 2nd Time: 12pm In conjunction with CPL’s Future of Work Institute and Cpl Specialist Talent, the Clinical Professionals Group invites you to our UK based Webinar Series “Perspectives on the Future of STEM”. During these times the world of work is changing for every industry, and STEM (Science, Technology, Engineering & Mathematics.) is no
“The most important thing is transforming our minds, for a new way of thinking, a new outlook: should we strive to develop a new inner world?” – Procurement Industry Analytics Report
Our latest industry analytics report features analysis on the procurement sector within the life sciences industry. Clinical Professionals Group CEO, Yvette Cleland comments: “As control of spend becomes more prominent in biopharmaceutical management’s message to the investor community, attention has been focused heavily again to the finance portfolio and most prominently through sourcing and procurement.
AstraZeneca will start clinical trials of two antibodies targeting SARS-CoV-2, the virus that causes COVID-19, within the next two months. The two candidates have emerged from a partnership with Vanderbilt University in the US – focusing on up to six coronavirus-targeting neutralising antibodies – which was signed in April. The antibodies have the potential to
Eli Lilly has recently begun dosing patients in the world’s first trial for treatment designed to attack SARS-CoV-2, the virus that causes COVID-19. This investigational treatment, referred to as LY-CoV555, is the first produced as a result of the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19. Scientists developed
Drug treatment, remdesivir – an anti-viral medicine that has been used against Ebola, appears to shorten recovery time for people with coronavirus is being made available on the NHS. Health Secretary Matt Hancock said it was probably the biggest step forward in the treatment of coronavirus since the crisis began. UK regulators say there is
Public Health England said the antibody test, developed by Swiss pharmaceutical company Roche, was a “very positive development”, Leading it to be approved in England. The blood test looks for antibodies to see if a person has already had the virus and might now have some immunity. Until now, officials have said such tests are
The new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 months to a few weeks. The ACCORD-2 collaboration will examine the effectiveness of repurposed medicines, potential new drugs, and currently unlicensed therapies in treating COVID-19 patients. Drug compounds that demonstrate effectiveness and safety in the early clinical trials stage
Researchers at Oxford University are working in what has been herald as an unprecedented vaccine development effort to prevent COVID-19, have begun screening healthy volunteers (aged 18-55) for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in
During times of change it can be challenging for organisations to focus on business strategy while maintaining employee engagement, productivity and wellness. Now more than ever, your leadership style, employer proposition and employee experience are important. As we all adapt to new ways of working implementing and adopting virtual interviews and onboarding are a challenge.